Lee S, Hong H, Lee C, Lee B, Kim S, Koh S
Korean J Intern Med. 2023; 38(5):661-671.
PMID: 37491721
PMC: 10493451.
DOI: 10.3904/kjim.2022.394.
Li R, Li X, Zhou H, Shi Y, Wang F, Wu T
Front Immunol. 2023; 14:1205046.
PMID: 37287984
PMC: 10242066.
DOI: 10.3389/fimmu.2023.1205046.
Alibaz-Oner F, Direskeneli H
Eur J Rheumatol. 2021; 8(4):217-222.
PMID: 33687828
PMC: 10176232.
DOI: 10.5152/eurjrheum.2020.20138.
Zhang L, Tian Y, Ye J, Lin C, Guan J
Orphanet J Rare Dis. 2019; 14(1):274.
PMID: 31779646
PMC: 6883595.
DOI: 10.1186/s13023-019-1228-9.
Miyagawa I, Nakano K, Iwata S, Nakayamada S, Saito K, Hanami K
Arthritis Res Ther. 2019; 21(1):151.
PMID: 31228955
PMC: 6589167.
DOI: 10.1186/s13075-019-1933-8.
Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.
Chen Y, Shen Y, Ma H, Cai J, Hua Y, Zou J
Medicine (Baltimore). 2018; 96(50):e9202.
PMID: 29390339
PMC: 5815751.
DOI: 10.1097/MD.0000000000009202.
Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?.
Kim D, Cheon J
Yonsei Med J. 2015; 57(1):22-32.
PMID: 26632379
PMC: 4696957.
DOI: 10.3349/ymj.2016.57.1.22.
Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.
Kaji M, Kishi T, Miyamae T, Nagata S, Yamanaka H, Fujikawa S
Case Rep Rheumatol. 2015; 2015:716138.
PMID: 26609459
PMC: 4644826.
DOI: 10.1155/2015/716138.
Gastrointestinal Behçet's disease: a review.
Skef W, Hamilton M, Arayssi T
World J Gastroenterol. 2015; 21(13):3801-12.
PMID: 25852265
PMC: 4385527.
DOI: 10.3748/wjg.v21.i13.3801.
Anti-TNF-alpha therapy and systemic vasculitis.
Jarrot P, Kaplanski G
Mediators Inflamm. 2014; 2014:493593.
PMID: 24719524
PMC: 3955590.
DOI: 10.1155/2014/493593.
Behçet's syndrome pathophysiology and potential therapeutic targets.
Emmi G, Silvestri E, Squatrito D, DElios M, Ciucciarelli L, Prisco D
Intern Emerg Med. 2014; 9(3):257-65.
PMID: 24415351
DOI: 10.1007/s11739-013-1036-5.
Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.
Li Y, Han Z, Wang X, Mo Z, Zhang W, Li A
BMC Gastroenterol. 2013; 13:167.
PMID: 24321021
PMC: 4029173.
DOI: 10.1186/1471-230X-13-167.
Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis.
Zhang M, Xu W, Wen P, Liang Y, Liu J, Pan H
Mol Vis. 2013; 19:1913-24.
PMID: 24049437
PMC: 3774576.
Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.
Sanchez-Cano D, Callejas-Rubio J, Ruiz-Villaverde R, Rios-Fernandez R, Ortego-Centeno N
Mediators Inflamm. 2013; 2013:286857.
PMID: 23983404
PMC: 3747407.
DOI: 10.1155/2013/286857.
Development of Immunopathogenesis Strategies to Treat Behçet's Disease.
Kose O
Patholog Res Int. 2012; 2012:261989.
PMID: 22550612
PMC: 3324914.
DOI: 10.1155/2012/261989.
